Eczema Free Forever™

Buoyed by new eczema data, AnaptysBio hits the fundraising button – FierceBiotech


FierceBiotech
Buoyed by new eczema data, AnaptysBio hits the fundraising button
FierceBiotech
After a single dose of ANB020, 75% of the 12 enrolled patients achieved an Eczema Area Severity Index score improvement of 50% (EASI-50) or more at day 15, 83% of patients at day 29 and 75% of patients achieved EASI-50 after 57 days or around two …
AnaptysBio Could Rival Regeneron Pharmaceuticals, Sanofi In …Investor’s Business Daily
AnaptysBio Reports Positive Topline Proof-of-Concept Data from Phase 2a Clinical Trial of ANB020 in Atopic DermatitisMarkets Insider

all 70 news articles »

eczema – Google News

Eczema Free Forever™